Access to new medicines to be faster
The National Institute for Health and Care Excellence and the Medicines and Healthcare products Regulatory Agency have described how the 10 Year Health Plan will lead to faster medicines access for patients in the NHS in England. Under a joint information sharing agreement, pharmaceutical companies will be invited to register early with both agencies to allow parallel decision making over licencing and value. It will mean more medicines receive approval for use on the NHS in England at the same time as they are licensed for use in the UK. It’s anticipated that patients in England will receive the newest medicines 3-6 months earlier as a result.